The CHEF1® Expression Technology Advantage for Accelerated Biologics Production, New Webinar Hosted by Xtalks

Press Release ( - TORONTO - Feb 05, 2018 - Biologics’ proprietary CHEF1® Expression System accelerates development of cell lines for cGMP biologics production. The innovative platform utilizes robust procedures and reliable raw materials, including chemically defined media, adapted Chinese hamster ovary (CHO) cells, and CHEF1 expression plasmids, to produce high levels of recombinant protein in rapid timeframes.

In this webinar the presenters will provide:

-A detailed technical review of the platform technology

-An explanation of how pool production enables fast and flexible delivery of early material

-A discussion of how small-scale models ensure seamless and successful manufacturing

-New data regarding CHEF1 performance

There will be two live broadcasts to accommodate viewers worldwide, on February 21 at 7 a.m. GMT for EU-Asia; and 11 a.m. EST (4 pm GMT) for North America. Click here for webinar details.


Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food, and medical device community. Every year thousands of industry practitioners (from life science, food, and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends, and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

For information about hosting a webinar visit


Nima Rajan

Tel: +1 (416) 977-6555 ext 352


Source : Xtalks Follow on Google News
Business Info :


Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login


If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.